Lv3
292 积分 2025-07-31 加入
Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Low HER2 Expression
23天前
已完结
Characteristics of gastric cancer around the world
23天前
已完结
中国人40842例胃腺癌HER2多中心检测结果分析
23天前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
1个月前
已完结
Improving Healthcare Utilization in Retired Self-Employed Workers: Evidence From an Experiment in France
1个月前
已完结
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trial
2个月前
已完结
Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Low HER2 Expression
2个月前
已完结
Trastuzumab Deruxtecan and Sacituzumab Govitecan for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer: A Cost-Effectiveness Analysis
2个月前
已完结
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
2个月前
已完结
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trial
2个月前
已完结
皖公网安备34019202002308
